Objective: Describe the early experience of bevacizumab treatment in four patients with type II neurofibromatosis.
Michael S. Jackson合作论文数1Gillian M. Borthwick合作论文数1
Emma J Crosbie合作论文数1Rachel Phelps合作论文数1S Lloyd合作论文数1a bala合作论文数1Richard Gallon合作论文数1
Neil Ryan合作论文数Bristol Medical School, University of Bristol;Department of Gynaecology Oncology, Royal Infirmary of Edinburgh;Bristol Medical School, University of Bristol1
Aileen King合作论文数School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London1
Heather Hampel合作论文数Department of Medical Oncology & Therapeutics Research, City of Hope;Division of Clinical Cancer Genomics, Beckman Research Institute, City of Hope1Freeman Simon R合作论文数1
Rachel Pearlman合作论文数Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center1Goodfellow Paul J合作论文数1
John Burn合作论文数Translational and Clinical Research Institute, Newcastle University;Faculty of Medical Sciences, Newcastle University;Northern Genetics Service1Scott a Rutherford合作论文数Department of Physics, Imperial College1Mauro Santibanez-Koref合作论文数1
